breast cancer blood test name

Release time ：Dec-27,2024

Blood tests for breast cancer commonly include tumor marker assays, such as CA 15-3 and CEA. These assays assist physicians in evaluating the presence, progression, and therapeutic response of breast cancer.

Firstly, CA 15-3 is a frequently utilized antigen associated with breast cancer, with a normal range typically between 0-28 U/mL. A result outside this range may suggest the presence or recurrence of breast cancer. Secondly, CEA (carcinoembryonic antigen) is a broad-spectrum tumor marker with a normal range of 0-5 ng/mL. Although CEA is not specific to breast cancer, it can be utilized to monitor disease changes in breast cancer patients. Additionally, other tumor marker assays, such as CA 125 and HER2/neu, may also be beneficial for the diagnosis and treatment of breast cancer in certain contexts.

It is important to recognize that tumor marker test results are not the sole criteria for diagnosing breast cancer; physicians often integrate these results with other diagnostic findings and clinical presentations to establish a final diagnosis. Therefore, if you are concerned about the possibility of breast cancer, please consult a healthcare provider promptly for professional guidance and treatment.